On the other hand, the tumor-promoting effect of the hepatitis C virus (HCV) transgene in the chronic inflammation-mediated HCC mouse model, was associated with increased Gal1 expression in the liver [16]. Here, LGALS1 is linked to hepatocellular carcinoma.